In 1989, Ft Detrick biological diseases experts were called on by the Virginia Department of Health and Hygiene when a commercial laboratory animal holding facility in Reston, Virginia, experienced an outbreak of an Ebola virus in its primate population. The potentially devastating outbreak was quickly handled, preventing what health officials feared could have had a terrible effect on humans. Author Richard Preston chronicled in The Hot Zone the rapid and effective response by Ft. Detrick scientists and soldiers. This in turn sparked at least one major movie (Outbreak), which based its story on the basic scenario of the Ebola outbreak The US Army established its offensive Biological Warfare program at Fort Detrick in 1943. The purpose of the program was twofold: develop defensive mechanisms against biological attack and develop weapons with which the United States could respond in kind if attacked by an enemy who used biological weapons. The offensive Biological Warfare program remained at Fort Detrick until November 1969, when the United States formally renounced the use of lethal biological agents and weapons, and all other methods of biological warfare and discontinued these offensive programs. From 1943 through 1953, biological warfare research on humans was observational in that it was done after occupational exposure incidents or accidents among workers in the biowarfare facilities. These incidents provided the station hospital the unique opportunity to study the …

Some vaccines are cultured on neoplastic (aka cancerous) cell lines, which DO cause cancer in certain strains of mice. What’s even scarier is that the vaccines (ie Varivax, MMR) have NEVER BEEN TESTED FOR ABILITY TO CAUSE CANCER. You might want to ask yourself WHY have they never been tested? Is this a risk you really want for at most partial and/or temporary protection from childhood diseases such as: -chickenpox, which is admitted to be a benign illness even by the manufacturer of Varivax, or -measles, mumps and rubella, which have become rare diseases and are admitted by the CDC to rarely cause complications? I’M SURE SOME PHARMA SHILLS WILL LAY INTO ME FOR PUTTING THIS VIDEO UP, BUT FOR ANYONE READING THIS, PLEASE CHECK THE SOURCES YOURSELVES, EVERYTHING I SAY IN THIS VIDEO IS TRUE. HeLa cells, immortal cell lines, cell line contamination and cancer: curezone.com Information from FDA on immortal (neoplastic) cell lines, safety and testing www.fda.gov HeLa cells and contamination: arpa.allenpress.com While lab culturing may indicate that so called immortal cells are not immediately changing to overt tumor cells, it is now well known in the scientific community that after these cells have been repeatedly cultured a certain number of times, something causes them to convert to a cancerous state. Normal embryo cells presumably represent a state in development which is genetically unstable, rendering them considerably more susceptible to malignant transformation.[76] When …

Lucy Dunn’s EDS 522 video presentation

Vasculitis psa short form. Public service announcement for Vasculitis one of the rare diseases.

Cartoon produced by Bruno Bozzetto to awaken about rare diseases.

Vasculitis psa short form. Public service announcement for Vasculitis one of the rare diseases.

Julie Carter is battling Chiari with her daughter Jade who also has syringomyelia. The support group they founded, Chiari People of Montana, devotes a tremendous amount of time, money, and energy promoting awareness of this condition.

Informativo sobre três doenças raras, Ictiose Harlequin, Neurofibromatose e Síndrome de Proteus. Information on three rare diseases, Harlequin ichthyosis, neurofibromatosis and Proteus syndrome

William Gahl, MD, Ph.D., presents “Rare Diseases and the NIH Undiagnosed Diseases Program” at the 2009 Bridging ehe Translational Divides symposium hosted by the Einstein-Montefiore Institute for Clinical and Translational Research. Dr. Gahl is the clinical director of the National Human Genome Research Institute, senior investigator of the Medical Genetics Branch, and head of the Human Biochemical Genetics Section at the National Institutes of Health.